Showing 10,041 - 10,060 results of 10,572 for search '"Tumor"', query time: 0.14s Refine Results
  1. 10041

    Analysis of Progress and Challenges of EGFR-Targeted Molecular Imaging in Cancer With a Focus on Affibody Molecules by Weizhi Chen MD, Baozhong Shen MD, PhD, Xilin Sun PhD

    Published 2019-01-01
    “…Epidermal growth factor receptor (EGFR)-targeted cancer therapy requires an accurate estimation of EGFR expression in tumors to identify responsive patients, monitor therapeutic effect, and estimate prognosis. …”
    Get full text
    Article
  2. 10042

    El estrés oxidativo: detonante fisiopatológico en la cardiomiopatía dilatada inducida por doxorrubicina by Yanet Hernández Matos, Liván Delgado Roche, Maité Ravelo González, Ronal Aroche Aportela

    Published 2011-10-01
    “…<p>La cardiomiopatía dilatada inducida por doxorrubicina constituye uno de los principales efectos indeseables del tratamiento de pacientes con tumores malignos. El estrés oxidativo constituye uno de los mecanismos fisiopatológicos que desempeñan un papel fundamental en la instauración de la enfermedad causada por este antibiótico del grupo de las antraciclinas. …”
    Get full text
    Article
  3. 10043

    The tyrosine kinase inhibitor lenvatinib is oxidized by rat cytochromes P450 and affects their expression in rat liver by Indra Radek, Jelínková Sandra, Kollárová Katarína, Zahumenská Petra, Dvořák Josef, Dušková Šárka, Dračínská Helena

    Published 2024-09-01
    “…Lenvatinib is an orally effective tyrosine kinase inhibitor used to treat several types of tumors, including progressive, radioiodine-refractory differentiated thyroid cancer and advanced renal cell carcinoma. …”
    Get full text
    Article
  4. 10044
  5. 10045

    Synthesis and biological evaluation of new tri-heterocyclic derivatives as anti-colorectal cancer agents by Benjamin Victoir, Océane Pertegaz, Elfi Ducrocq, Marion Polomski, Maxime Guéguinou, William Raoul, Cécile Croix, Gildas Prié

    Published 2025-01-01
    “…Pharmacomodulations were strategically performed, and the in vitro activities of all tri-heterocyclic derivatives were assessed on HT29 and Lovo colorectal cancer cell lines, as well as on the non-tumoral NCM356 colonic epithelial cell line derived from normal mucosa. …”
    Get full text
    Article
  6. 10046

    TRIZ Theory and the Method of Cancer Document Selection for Chemical Complexes and Innovation Schemes of Meta-Analysis with Lymphomas as an Example by Yan Huiquan, Lyu Penghui, Wang Ling, Yu Zhiming

    Published 2020-01-01
    “…In the face of the growing incidence of malignant tumors (about 3.929 million, data issued in January 2019) and the death rate (about 2.338 million, data issued in January 2019) and the limitation of the application of informatics in cancer treatment, this paper tried to use TRIZ theory to deduce new ideas about cancer treatments, perform literature analysis on schemes, and make retrieval strategy for meta-analyses on cancer therapy. …”
    Get full text
    Article
  7. 10047

    Arterial Calcium Stimulation with Hepatic Venous Sampling in the Localization Diagnosis of Endogenous Hyperinsulinism by Paloma Moreno-Moreno, María Rosa Alhambra-Expósito, Aura Dulcinea Herrera-Martínez, Rafel Palomares-Ortega, Luis Zurera-Tendero, Juan José Espejo Herrero, María Angeles Gálvez-Moreno

    Published 2016-01-01
    “…This technique allows the localization of intrapancreatic insulinomas and represents useful tool for the diagnosis and surgical management of these tumors.…”
    Get full text
    Article
  8. 10048
  9. 10049

    Financial Toxicity and Kidney Disease in Children and Adults: A Scoping Review by Siligato R, Gembillo G, De Giorgi A, Di Maria A, Scichilone LM, Capone M, Vinci FM, Nicoletti S, Bondanelli M, Malaventura C, Storari A, Santoro D, Dionisi S, Fabbian F

    Published 2025-01-01
    “…Three studies reported the impact of FT on nephrolithiasis, and 3 studies analyzed the link between FT and renal tumors. The methods used for detecting FT differed and were based on consultations, questionnaires, expenditures and database records analysis. …”
    Get full text
    Article
  10. 10050
  11. 10051

    RET inhibition overcomes resistance to combined CDK4/6 inhibitor and endocrine therapy in ER+ breast cancer by Charlotte K. Kindt, Sidse Ehmsen, Sidse Ehmsen, Sidse Ehmsen, Sofie Traynor, Benedetta Policastro, Nikoline Nissen, Mie K. Jakobsen, Monique F. Hundebøl, Lene E. Johansen, Martin Bak, Elsa Arbajian, Johan Staaf, Henrik J. Ditzel, Henrik J. Ditzel, Henrik J. Ditzel, Carla L. Alves

    Published 2025-01-01
    “…We further observed a shorter median survival to combined CDK4/6i and endocrine therapy in patients with RET-positive compared to RET-negative tumors, but this difference did not reach statistical significance.ConclusionsOur findings show that RET is overexpressed in ER+ metastatic breast cancer resistant to combined CDK4/6i and endocrine therapy, rendering RET inhibition a promising therapeutic approach for patients who experience disease progression on combined CDK4/6i and endocrine therapy.…”
    Get full text
    Article
  12. 10052

    Stably Integrated for Assessment of Invasion Kinetics by Kelly N. Flentie, Min Qi, Seth T. Gammon, Yasmin Razia, Felix Lui, Luciano Marpegan, Aashish Manglik, David Piwnica-Worms, Jeffrey S. McKinney

    Published 2008-09-01
    “…Salmonella Typhimurium is a common cause of gastroenteritis in humans and also localizes to neoplastic tumors in animals. Invasion of specific eukaryotic cells is a key mechanism of Salmonella interactions with host tissues. …”
    Get full text
    Article
  13. 10053

    Iodine-131 Metaiodobenzylguanidine Therapy for Neuroblastoma: Reports So Far and Future Perspective by Daiki Kayano, Seigo Kinuya

    Published 2015-01-01
    “…Neuroblastoma, which derives from neural crest, is the most common extracranial solid cancer in childhood. The tumors express the norepinephrine (NE) transporters on their cell membrane and take in metaiodobenzylguanidine (MIBG) via a NE transporter. …”
    Get full text
    Article
  14. 10054

    Spatial stochastic models of cancer: Fitness, migration, invasion by Natalia L. Komarova

    Published 2013-03-01
    “…Cancer progression is driven by genetic and epigenetic events giving rise to heterogeneity of cellphenotypes, and by selection forces that shape the changingcomposition of tumors. The selection forces are dynamic and depend onmany factors. …”
    Get full text
    Article
  15. 10055

    Premalignant Lesions in the Kidney by Ziva Kirkali, Kutsal Yorukoglu

    Published 2001-01-01
    “…Progression to invasive carcinoma is described in experimental cancer models, and in some human renal tumors. Similar molecular alterations are found in some putative premalignant changes. …”
    Get full text
    Article
  16. 10056

    Chemokines in Renal Diseases by Stephan Segerer, Peter J. Nelson

    Published 2005-01-01
    “…Therefore, it is not surprising that chemokines play important roles in a wide range of human diseases, including genetic immunodeficiencies, infections, autoimmune diseases, and malignant tumors. In this report, we have reviewed recent developments (since mid 2003) in chemokines in renal diseases. …”
    Get full text
    Article
  17. 10057

    ChatGPT-4.0 in oral and maxillofacial radiology: prediction of anatomical and pathological conditions from radiographic images by Shila Kahalian, Marieh Rajabzadeh, Melisa Öçbe, Mahmut Sabri Medisoglu

    Published 2024-12-01
    “…There was not a significant difference in accurate diagnosis of anatomical landmarks, cysts, and tumors (p&amp;gt;0.05). However, including internal structure information improved the diagnostic accuracy (p&amp;lt;0.05) Conclusion: GPT-4.0 showed a tendency to misdiagnose closely located anatomical structures and by adding additional clues its performance showed improvement, while its ability to recognize diverse differential diagnoses remains limited.…”
    Get full text
    Article
  18. 10058

    Clinicopathological analysis of sclerosing angiomatoid nodular transformation in the spleen by Shufei Wei, Yongliang Han, Yingyong Hou, Liangliang Wang

    Published 2023-07-01
    “…Results: Fourteen cases were complicated with benign tumors of the liver, pancreas, kidney, uterus, and prostate. …”
    Get full text
    Article
  19. 10059

    The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence by Goran B. Klintmalm, Björn Nashan

    Published 2014-01-01
    “…In this review we surveyed the literature for reports of the use of mTOR inhibitors in adult liver transplantation with respect to renal function, efficacy, safety, neurological symptoms, de novo tumors, and the recurrence of HCC and HCV. The results of our review indicate that mTOR inhibitors are associated with efficacy comparable to CNIs while having benefits on renal function in liver transplantation. …”
    Get full text
    Article
  20. 10060

    Extramedullary Plasmacytoma of the Oral Cavity: A Rare Case in the Buccal Mucosa by Armin Khaleghi, Nafise Shamloo

    Published 2025-01-01
    “…ABSTRACT Extramedullary plasmacytomas (EMP) are uncommon solitary tumors composed of neoplastic plasma cells occurring outside the bone. …”
    Get full text
    Article